CVE-2017-12374

Public Exploit

Description

The ClamAV AntiVirus software versions 0.99.2 and prior contain a vulnerability that could allow an unauthenticated, remote attacker to cause a denial of service (DoS) condition on an affected device. The vulnerability is due to a lack of input validation checking mechanisms during certain mail parsing operations (mbox.c operations on bounce messages). If successfully exploited, the ClamAV software could allow a variable pointing to the mail body which could cause a used after being free (use-after-free) instance which may lead to a disruption of services on an affected device to include a denial of service condition.

Category

7.5
CVSS
Severity: High
CVSS 3.0 •
CVSS 2.0 •
EPSS 5.54% Top 15%
Vendor Advisory ubuntu.com Vendor Advisory ubuntu.com Vendor Advisory clamav.net Vendor Advisory clamav.net
Affected: n/a ClamAV AntiVirus software versions 0.99.2 and prior
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2017-12374?
CVE-2017-12374 has been scored as a high severity vulnerability.
How to fix CVE-2017-12374?
To fix CVE-2017-12374, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2017-12374 being actively exploited in the wild?
It is possible that CVE-2017-12374 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~6% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2017-12374?
CVE-2017-12374 affects n/a ClamAV AntiVirus software versions 0.99.2 and prior.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.